Logo image
In Vitro Efficacy of Moxidectin versus Ivermectin against Sarcoptes scabiei
Journal article   Peer reviewed

In Vitro Efficacy of Moxidectin versus Ivermectin against Sarcoptes scabiei

Kate E Mounsey, Shelley F Walton, Ashlee Innes, Skye Cash-Deans and James S McCarthy
Antimicrobial Agents and Chemotherapy, Vol.61(8), e00381-17
2017
url
https://doi.org/10.1128/AAC.00381-17View
Published Version

Abstract

ivermectin moxidectin Sarcoptes scabiei scabies treatment
Moxidectin is under consideration for development as a treatment for human scabies. As some arthropods show decreased sensitivity to moxidectin relative to ivermectin, it was important to assess this for Sarcoptes scabiei. In-vitro assays showed that the concentration of moxidectin required to kill 50% of mites was lower compared to ivermectin (0.5 μM vs 1.8 μM at 24 hours, p <0.0001). This finding provides further support for moxidectin as a candidate for the treatment of human scabies.

Details

Metrics

3 File views/ downloads
638 Record Views

InCites Highlights

These are selected metrics from InCites Benchmarking & Analytics tool, related to this output

Collaboration types
Domestic collaboration
Web Of Science research areas
Microbiology
Pharmacology & Pharmacy

UN Sustainable Development Goals (SDGs)

This output has contributed to the advancement of the following goals:

#3 Good Health and Well-Being

Source: InCites

Logo image